Effect of polyethylene glycol on the cardiovascular response of the dog to autonomic agents.
D000109:Acetylcholine / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001337:Autonomic Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D002339:Carotid Arteries / Q000502:physiology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D006018:Glycols / Q000494:pharmacology*; D006614:Hindlimb / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D010656:Phenylephrine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011095:Polyethylenes / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D013015:Sotalol / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D001337:Autonomic Agents; D005730:Ganglionic Blockers; D006018:Glycols; D010879:Piperazines; D011095:Polyethylenes; D010656:Phenylephrine; D006632:Histamine; D011433:Propranolol; D013015:Sotalol; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine